Welcome to the Intellegens newsletter, where we share the latest news,
developments, and achievements from the team at Intellegens.
Want to receive new editions of our Newsletter straight to your inbox?
Click here to subscribe!
Machine learning powers battery insights
We’re seeing a lot of interest in machine learning applied to battery applications at the moment, so the recent publication of a paper in Cell Reports Physical Science is timely. Scientists from the University of Birmingham, Intellegens, Ansys, and the Faraday Institute applied machine learning to optimise formulation and manufacturing parameters for the electrodes of lithium-ion batteries. The proposed electrode was manufactured and showed excellent lifecycle and capacity, as predicted.
Validation of antimalarial drug design published
Another recent paper in the Journal of Medicinal Chemistry covers the Open Source Malaria drug discovery competition. Intellegens and our partner Optibrium performed well in this global challenge to predict potential antimalarial compounds. Two years on from the original work, this paper summarises the contest and the subsequent synthesis and testing of the proposed molecules. The compound predicted by Alchemite™ machine learning showed good potency, as predicted. Interestingly, the project team commented that they might have dismissed the compound as “ill advised” if recommended by a human chemist, showing the potential of machine learning to identify productive new discovery pathways.
Latest Alchemite™ enables new data and model insights
The Intellegens development team continually enhances the Alchemite™ deep learning software. Recent additions include more control when classifying outliers in a dataset, making it easier to understand data quality. There is also an improved capability for testing a model against an unseen dataset, providing better information on model performance. Alchemite™ goes beyond implementing a powerful machine learning algorithm to deliver valuable insights into both the user’s data and the models derived from that data.
Alchemite™ user community meets
Intellegens hosted the second Alchemite™ Focus Group last month, bringing together a diverse set of chemicals, materials, and manufacturing organisations to discuss how to maximise value from deep learning technology as they design and optimise products and processes. Thanks are particularly due to the case study presenters from OCAS NV (optimising steel properties) and the AMRC (composite tooling). A report is available on our website, linked below.
New intellegens.com launched
We’re delighted to have launched our new-look website at our new intellegens.com web address. Bookmark the site for the latest news, case studies, publications, webinars, and events from Intellegens.
On the blog - applied machine learning
A new feature on the website is the Intellegens blog which we’ll be using to give an informal take on some of the key issues when applying machine learning in industry. We’re starting with a series of articles covering some of the main reasons why product development teams turn to machine learning – and some of the challenges that they experience when they do. The first two articles are linked below. Follow us on LinkedIn for a notification when a new blog is published and to add your thoughts via LinkedIn comments.
More opportunities at Intellegens
We’re growing all the time, and we’ve added yet more jobs to our recruitment list this month. If you know someone who would love a new challenge and a welcoming work environment at an exciting, growing, machine learning company – tell them to contact us. Current opportunities include :
After a very busy end to the year, we’re currently putting together our events program for 2022. Here are just a few places where we’ll be discussing machine learning in the first months of the new year.
24th Jan. AI: Facts, Fictions, Futures (Loughborough, UK) – Intellegens CTO Dr Gareth Conduit is a visiting fellow during this week for discussions on ‘AI for Interdisciplinary Scientific Discovery’.
2nd Feb. Medical Advanced Materials (Birmingham, UK) – Dr Tom Whitehead from Intellegens is speaking on machine learning applied to materials design for medical applications.
14th Mar. AI in Drug Discovery (London, UK). Our drug discovery partner Optibrium will be speaking at this event, including coverage of their Alchemite™-powered software solution.
If you missed one of our webinars this year, why not take a look at our library of webinar recordings? It includes compelling presentations on the use of machine learning from Domino Printing Sciences, the AMRC, NASA, and Lucideon.
And finally... best wishes for the holidays and 2022
The Intellegens team would like to thank all of our partners, customers, and other contacts for their support and interest in 2021 and to wish you all the best for the upcoming holiday season and for 2022.